Identification of Fasnall as a therapeutically effective Complex I inhibitor
D. Mukha, J. Dessain, S. O'Connor, K. Pniewski, F. Bertolazzi, J. Patel, M. C. Mullins, Z. T. Schug
This study identifies Fasnall as a Complex I inhibitor that mimics FASN inhibition, showing anti-tumor effects without neurological side effects.
bioRxiv · May 3, 2024 · PreprintCancer Biology